Skip to content

A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China

A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05045092
Enrollment
0
Registered
2021-09-16
Start date
2024-01-01
Completion date
2027-12-31
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Life Support, Extracorporeal Membrane Oxygenation, Mortality, Neonate, Neurodevelopment

Brief summary

Descriptive study of two-year follow-up outcomes of surviving neonates who are enrolled in the Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS) from 2022 to 2024.

Detailed description

This study aims to describe the six -month, one-year and two-year neurodevelopmental outcomes of survivors of neonatal ECLS treatment in the Chi-NELS. The study population will be neonates who receive ECLS support within 28 days of life and are enrolled in the Chi-NELS. These infants will be prospectively followed for two years. Mortality, growth, and neurodevelopmental outcomes will be assessed at six months, one year and two years.

Interventions

None listed

Sponsors

Chinese Neonatal Network
CollaboratorOTHER
Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 1 Months
Healthy volunteers
No

Inclusion criteria

* Infants who receive extracorporeal life support (ECLS) at ≤28 days of life from 2022.1.1-2023.12.31 * Survive to the first ICU discharge

Exclusion criteria

* Infants who died during the ECLS hospitalization * Parental refusal to follow-up

Design outcomes

Primary

MeasureTime frameDescription
Mortality or severe/moderate neurodevelopmental delay at two-year oldAt two-year oldIt is a binary variable (1/0). If mortality or severe/moderate neurodevelopmental delay occur in the participent, the value of this varible is 1.

Secondary

MeasureTime frameDescription
Length of infants at six monthsAt six months
Head circumference of infants at six monthsAt six months
Body weight of infants at one year oldAt one year old
Length of infants at one year oldAt one year old
Head circumference of infants at one year oldAt one year old
Body weight of infants at six monthsAt six months
Length of infants at two years oldAt two years old
Head circumference of infants at two years oldAt two years old
Severe/moderate neurodevelopmental delay at six monthsAt six monthsProportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Severe/moderate neurodevelopmental delay at one year oldAt one year oldProportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Severe/moderate neurodevelopmental delay at two years oldAt two years oldProportion of infants with severe/moderate neurodevelopmental delay according to the development scale
Body weight of infants at two years oldAt two years old

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026